SC 13D/A

UNITED STATESSECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549

SCHEDULE 13D(Rule 13d-101)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO §

240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a)

Amendment No. 7

HealthWarehouse.com, Inc.(formerly Clacendix, Inc. / formerly Ion Networks, Inc. / formerly MicroFrame, Inc.)

(Name of Issuer)

Common Stock, par value $0.001(Title of Class of Securities)

46205P100(CUSIP Number)

Jeffrey T. Holtmeier

Rx Investor Value Corporation

5027 Madison Road, Suite 200

Cincinnati, OH 45227

513.891.8914

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

September 6, 2016

(Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits.  See §240.13d-7 for other parties to whom copies are to be sent.

^*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

1	NAME OF REPORTING PERSONS Rx Investor Value Corporation
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP  (a) ☐ (b) ☒
3	SEC USE ONLY
4	SOURCE OF FUNDS WC
5	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)☐
6	CITIZENSHIP OR PLACE OF ORGANIZATION Delaware
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH			7	SOLE VOTING POWER 1,100
			8	SHARED VOTING POWER 0
			9	SOLE DISPOSITIVE POWER 1,100
			10	SHARED DISPOSITIVE POWER 0
11		AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,100
12		CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES  CERTAIN SHARES*☐
13		PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 0.1%
14		TYPE OF REPORTING PERSON* CO

1	NAME OF REPORTING PERSONS Jeffrey T. Holtmeier
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP  (a) ☐ (b) ☒
3	SEC USE ONLY
4	SOURCE OF FUNDS WC
5	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)☐
6	CITIZENSHIP OR PLACE OF ORGANIZATION United States
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH			7	SOLE VOTING POWER 19,900
			8	SHARED VOTING POWER 21,000
			9	SOLE DISPOSITIVE POWER 19,900
			10	SHARED DISPOSITIVE POWER 21,000
11		AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 21,000
12		CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDESCERTAIN SHARES*☐
13		PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 0.1%
14		TYPE OF REPORTING PERSON* IN

1	NAME OF REPORTING PERSONS GENext, LLC
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP  (a) ☐ (b) ☒
3	SEC USE ONLY
4	SOURCE OF FUNDS WC
5	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)☐
6	CITIZENSHIP OR PLACE OF ORGANIZATION Ohio
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH			7	SOLE VOTING POWER 19,900
			8	SHARED VOTING POWER 21,000
			9	SOLE DISPOSITIVE POWER 19,900
			10	SHARED DISPOSITIVE POWER 21,000
11		AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 21,000
12		CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*☐
13		PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 0.1%
14		TYPE OF REPORTING PERSON* OO

1	NAME OF REPORTING PERSONS Robert Smyjunas
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP  (a) ☐ (b) ☒
3	SEC USE ONLY
4	SOURCE OF FUNDS WC, PF
5	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)☐
6	CITIZENSHIP OR PLACE OF ORGANIZATION United States
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH			7	SOLE VOTING POWER 225,300
			8	SHARED VOTING POWER 226,400
			9	SOLE DISPOSITIVE POWER 225,300
			10	SHARED DISPOSITIVE POWER 226,400
11		AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 226,400
12		CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*☐
13		PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 0.1%
14		TYPE OF REPORTING PERSON* IN

1	NAME OF REPORTING PERSONS Stephen J. Weiss
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP  (a) ☐ (b) ☒
3	SEC USE ONLY
4	SOURCE OF FUNDS WC
5	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)☐
6	CITIZENSHIP OR PLACE OF ORGANIZATION United States
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH			7	SOLE VOTING POWER 1,020,000
			8	SHARED VOTING POWER
			9	SOLE DISPOSITIVE POWER 1,020,000
			10	SHARED DISPOSITIVE POWER
11		AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,020,000
12		CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*☐
13		PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 2.4%
14		TYPE OF REPORTING PERSON* IN

1	NAME OF REPORTING PERSONS SCW Holdings, LLP
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP  (a) ☐ (b) ☒
3	SEC USE ONLY
4	SOURCE OF FUNDS WC
5	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)☐
6	CITIZENSHIP OR PLACE OF ORGANIZATION Arizona
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH			7	SOLE VOTING POWER 1,020,000
			8	SHARED VOTING POWER
			9	SOLE DISPOSITIVE POWER 1,020,000
			10	SHARED DISPOSITIVE POWER
11		AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,020,000
12		CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*☐
13		PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 2.4%
14		TYPE OF REPORTING PERSON* PN

1	NAME OF REPORTING PERSONS Mark Douglas Scott
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP  (a) ☐ (b) ☒
3	SEC USE ONLY
4	SOURCE OF FUNDS WC
5	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)☐
6	CITIZENSHIP OR PLACE OF ORGANIZATION Canada
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH			7	SOLE VOTING POWER 4,480,861
			8	SHARED VOTING POWER
			9	SOLE DISPOSITIVE POWER 4,480,861
			10	SHARED DISPOSITIVE POWER
11		AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 4,480,861
12		CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES  CERTAIN SHARES*☐
13		PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 10.7%
14		TYPE OF REPORTING PERSON* IN

1	NAME OF REPORTING PERSONS Cormag Holdings, Ltd.
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP  (a) ☐ (b) ☒
3	SEC USE ONLY
4	SOURCE OF FUNDS WC
5	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)☐
6	CITIZENSHIP OR PLACE OF ORGANIZATION Canada
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH			7	SOLE VOTING POWER 4,480,861
			8	SHARED VOTING POWER
			9	SOLE DISPOSITIVE POWER 4,480,861
			10	SHARED DISPOSITIVE POWER
11		AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 4,480,861
12		CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*☐
13		PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 10.7%
14		TYPE OF REPORTING PERSON* CO

1	NAME OF REPORTING PERSONS Hong Penner
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP  (a) ☐ (b) ☒
3	SEC USE ONLY
4	SOURCE OF FUNDS WC
5	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)☐
6	CITIZENSHIP OR PLACE OF ORGANIZATION Canada
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH			7	SOLE VOTING POWER 2,500,000
			8	SHARED VOTING POWER
			9	SOLE DISPOSITIVE POWER 2,500,000
			10	SHARED DISPOSITIVE POWER
11		AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,500,000
12		CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*☐
13		PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 5.9%
14		TYPE OF REPORTING PERSON* IN

1	NAME OF REPORTING PERSONS Osgar Holdings, Ltd.
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP  (a) ☐ (b) ☒
3	SEC USE ONLY
4	SOURCE OF FUNDS WC
5	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)☐
6	CITIZENSHIP OR PLACE OF ORGANIZATION Canada
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH			7	SOLE VOTING POWER 2,500,000
			8	SHARED VOTING POWER
			9	SOLE DISPOSITIVE POWER 2,500,000
			10	SHARED DISPOSITIVE POWER
11		AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,500,000
12		CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*☐
13		PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 5.9%
14		TYPE OF REPORTING PERSON* CO

1	NAME OF REPORTING PERSONS Bruce Bedrick
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP  (a) ☐ (b) ☒
3	SEC USE ONLY
4	SOURCE OF FUNDS PF
5	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)☐
6	CITIZENSHIP OR PLACE OF ORGANIZATION United States
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH			7	SOLE VOTING POWER 5,850,000
			8	SHARED VOTING POWER
			9	SOLE DISPOSITIVE POWER 5,850,000
			10	SHARED DISPOSITIVE POWER
11		AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 5,850,000
12		CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*☐
13		PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 13.9%
14		TYPE OF REPORTING PERSON* IN

1	NAME OF REPORTING PERSONS Lynn Peppel
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP  (a) ☐ (b) ☒
3	SEC USE ONLY
4	SOURCE OF FUNDS WC
5	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)☐
6	CITIZENSHIP OR PLACE OF ORGANIZATION United States
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH			7	SOLE VOTING POWER 1,147,755
			8	SHARED VOTING POWER
			9	SOLE DISPOSITIVE POWER 1,147,755
			10	SHARED DISPOSITIVE POWER
11		AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,147,755
12		CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*☐
13		PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 2.7%
14		TYPE OF REPORTING PERSON* IN

1	NAME OF REPORTING PERSONS Cape Bear Partners LLC
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP  (a) ☐ (b) ☒
3	SEC USE ONLY
4	SOURCE OF FUNDS WC
5	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)☐
6	CITIZENSHIP OR PLACE OF ORGANIZATION Delaware
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH			7	SOLE VOTING POWER 1,147,755
			8	SHARED VOTING POWER
			9	SOLE DISPOSITIVE POWER 1,147,755
			10	SHARED DISPOSITIVE POWER
11		AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,147,755
12		CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*☐
13		PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 2.7%
14		TYPE OF REPORTING PERSON* OO

1	NAME OF REPORTING PERSONS Anthony W. Liberati
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP  (a) ☐ (b) ☒
3	SEC USE ONLY
4	SOURCE OF FUNDS WC
5	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)                   ☐
6	CITIZENSHIP OR PLACE OF ORGANIZATION United States
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH			7	SOLE VOTING POWER 713,295
			8	SHARED VOTING POWER
			9	SOLE DISPOSITIVE POWER 713,295
			10	SHARED DISPOSITIVE POWER
11		AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 713,295
12		CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*             ☐
13		PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 1.6%
14		TYPE OF REPORTING PERSON* IN

1	NAME OF REPORTING PERSONS LFLP, Ltd.
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP  (a) ☐ (b) ☒
3	SEC USE ONLY
4	SOURCE OF FUNDS WC
5	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)                   ☐
6	CITIZENSHIP OR PLACE OF ORGANIZATION Pennsylvania
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH			7	SOLE VOTING POWER 713,295
			8	SHARED VOTING POWER
			9	SOLE DISPOSITIVE POWER 713,295
			10	SHARED DISPOSITIVE POWER
11		AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 713,295
12		CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*             ☐
13		PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 1.6%
14		TYPE OF REPORTING PERSON* PN

1	NAME OF REPORTING PERSONS Patrick Delaney
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP  (a) ☐ (b) ☒
3	SEC USE ONLY
4	SOURCE OF FUNDS PF
5	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)☐
6	CITIZENSHIP OR PLACE OF ORGANIZATION United States
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH		7	SOLE VOTING POWER 360,000
		8	SHARED VOTING POWER
		9	SOLE DISPOSITIVE POWER 360,000
		10	SHARED DISPOSITIVE POWER
11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 360,000
12	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*☐
13	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 0.1%
14	TYPE OF REPORTING PERSON* IN

1	NAME OF REPORTING PERSONS Brian Ross
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP  (a) ☐ (b) ☒
3	SEC USE ONLY
4	SOURCE OF FUNDS
5	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)☐
6	CITIZENSHIP OR PLACE OF ORGANIZATION United States
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH			7	SOLE VOTING POWER 0
			8	SHARED VOTING POWER 0
			9	SOLE DISPOSITIVE POWER 0
			10	SHARED DISPOSITIVE POWER 0
11		AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 0
12		CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*☐
13		PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 0%
14		TYPE OF REPORTING PERSON* IN

1	NAME OF REPORTING PERSONS Vincent Rinaldi
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP  (a) ☐ (b) ☒
3	SEC USE ONLY
4	SOURCE OF FUNDS
5	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)☐
6	CITIZENSHIP OR PLACE OF ORGANIZATION United States
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH			7	SOLE VOTING POWER 0
			8	SHARED VOTING POWER 0
			9	SOLE DISPOSITIVE POWER 0
			10	SHARED DISPOSITIVE POWER 0
11		AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 0
12		CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*☐
13		PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 0%
14		TYPE OF REPORTING PERSON* IN

Explanatory Note

This Amendment No. 7 to Schedule 13D (this "Amendment") amends the Schedule 13D (as amended by Amendment No. 1 filed on August 9, 2016, Amendment No. 2 filed on August 11, 2016, Amendment No. 3 filed on August 12, 2016, Amendment No. 4 filed on August 22, 2016, Amendment No. 5 filed on August 24, and Amendment No. 6 filed on August 25, 2016 the "Schedule 13D") originally filed with the SEC on August 2, 2016 with respect to the shares of common stock, par value $0.001 per share, (the "Common Stock") of HealthWarehouse.com, Inc. (the "Company" or "Issuer") owned by the Reporting Persons identified therein. Capitalized terms used but not otherwise defined herein have the respective meanings ascribed to them in the Schedule 13D. Except as set forth below, all previous Items are unchanged.

Item 4.Purpose of the Transaction

 Item 4 of Schedule 13D is amended by adding the following:

On September 7, 2016, RIVC issued the press release attached hereto and incorporated herein by reference as Exhibit 99.9.

Item 5.Interest in Securities of the Issuer.

At the conclusion of the Annual Meeting of Stockholders of the Issuer on September 2, 2016, the Reporting Persons ceased acting as a "group" and the Reporting Persons ceased to be beneficial owners of more than five percent of the Company's Common Stock as reported herein.

Item 6. Contacts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.

The agreement set forth as Exhibit 7.1 to the Schedule 13D is terminated.

Item 7.Material to be Filed as Exhibits

Exhibit 99.1.	Joint Filing Agreement (incorporated by reference to the Schedule 13D filed by the Reporting Persons on August 2, 2016).
Exhibit 99.2	Letter from Rx Investor Value Corporation to HealthWarehouse.com, Inc., dated June 27, 2016 (incorporated by reference to the Schedule 13D filed by the Reporting Persons on August 2, 2016).
Exhibit 99.3	Letter from Rx Investor Value Corporation to HealthWarehouse.com, Inc., dated July 25, 2016 (incorporated by reference to the Schedule 13D filed by the Reporting Persons on August 2, 2016).
Exhibit 99.4	Letter from Rx Investor Value Corporation to HealthWarehouse.com, Inc., dated August 5, 2016 (incorporated by reference to the Amendment No. 1 to the Schedule 13D filed by the Reporting Persons on August 9, 2016).
Exhibit 99.5	Letter from Rx Investor Value Corporation to HealthWarehouse.com, Inc., dated August 10, 2016 (incorporated by reference to the Amendment No. 2 to the Schedule 13D filed by the Reporting Persons on August 11, 2016).
Exhibit 99.6	Letter from RX Investor Value Corporation to HealthWarehouse.com, Inc. dated August 22, 2016 (incorporated by reference to the Amendment No. 4 to the Schedule 13D filed by the Reporting Persons on August 22, 2016).
Exhibit 99.7	Letter from RX Investor Value Corporation to HealthWarehouse.com, Inc. stockholders dated August 24, 2016 (incorporated by reference to the Amendment No. 5 to the Schedule 13D filed by the Reporting Persons on August 24, 2016).
Exhibit 99.8	Press Release dated August 24, 2016 (incorporated by reference to the Amendment No. 6 to the Schedule 13D filed by the Reporting Persons on August 25, 2016).
Exhibit 99.9	Press Release dated September 7, 2016.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: September 9, 2016
	RX INVESTOR VALUE CORPORATION
	By:  /s/ Jeffrey T. Holtmeier
	Jeffrey T. Holtmeier
	President

EX-99.9

EXHIBIT 99.9

Contact

Michael R. Levin

847.830.1479

m.levin@comcast.net

FOR IMMEDIATE RELEASE

Rx Investor Value Slate of Stockholder-Nominated Directors Elected to Board of Directors at HealthWarehouse.com

Stockholders Elect All Four Nominees on RIVC's Slate to HEWA Board of Directors Based on Preliminary Voting Results

CINCINNATI – (September 7, 2016) – Rx Investor Value Corporation (RIVC), a stockholder of HealthWarehouse.com, Inc. (OTCQB: HEWA), announced that preliminary vote totals substantiate that at the recently-concluded Annual Meeting of Stockholders held on September 2, 2016, stockholders elected all four of RIVC's nominees to the HEWA Board of Directors by a substantial margin over the incumbent directors.

Healthwarehouse.com is a retail mail-order pharmacy and healthcare e-commerce company that sells prescription and over-the-counter pharmaceuticals online.

In July, 2016, RIVC, a group of independent HEWA investors, nominated four independent directors for election to the Board.

According to the preliminary voting results, stockholders cast approximately 45.4 million votes, representing over 94% of the approximately 48.2 million eligible votes. Of these votes, each of the stockholder-sponsored nominees received over 23.3 million votes, or more than 51% of the total votes cast at the meeting. In contrast, the highest number of votes received by any incumbent director was less than 21.8 million votes, or 48% of the number of votes cast. After subtracting votes held by HEWA affiliates (including officers, directors, HEWA's senior lender and family members and affiliates of these persons, and including approximately 4.5 million shares the Board granted the day before the record date), non-affiliates voting for the incumbent directors represented only 12.6% of the total votes cast at the meeting.  As a result, non-affiliate stockholders voted for the RIVC supported nominees over the incumbent directors by a more than four to one margin.

"We are elated that stockholders agree with our vision and plan for HEWA," said Jeff Holtmeier, a stockholder in HEWA, a director nominee, and together with Rob Smyjunas, one of the co-founders and officers of RIVC. "The outstanding stockholder turnout resulted from our fellow HealthWarehouse.com investors' careful consideration of the issues. Our independent director candidates received over four times the number of non-affiliate votes than the incumbent directors. We are encouraged that the stockholders have sent such a resounding message of support for our efforts to drive meaningful change at HEWA, bring true accountability to HEWA leadership, and restore stockholder value. We have a tremendous amount of work ahead to transform HEWA, and think the new directors represent the right combination of business experience and online pharmacy expertise to get us there. We look forward to working with shareholders to turn around HEWA, and invite input from all shareholders as we begin this process."

In addition to Holtmeier, stockholders also elected Mark Scott, Brian Ross and Dr. Stephen Weiss to the Board. Subject to certification of the final results by the independent inspector of elections, the new directors begin their terms immediately and will serve through the HEWA 2017 Annual Meeting of stockholders.

 "The conclusion of this proxy contest marks not an end but a beginning. We look forward to working collaboratively with HEWA's hardworking, dedicated and talented employees to set the company on a course to improve performance and restore stockholder value. HEWA has tremendous potential value and we are confident there is much we can and will do to refocus it and steer it in a new strategic direction."

Advising RIVC on this project were Michael R. Levin (strategy), Thomas W. Bosse (strategy and legal), and F. Mark Reuter of Keating Muething & Klekamp (legal). Okapi Partners served as proxy solicitor for RIVC.

"We appreciate the invaluable advice from Mike Levin, Tom Bosse, and Mark Reuter," continued Holtmeier. "The team at Okapi Partners, including Bruce Goldfarb, Michael Fein, Teresa Huang and Chuck Garske, contributed significantly to this favorable outcome for all HEWA stockholders."

About Rx Investor Value Corporation

Rx Investor Value Corporation ("RIVC") is an entity formed by Rob Smyjunas and Jeffrey Holtmeier to promote positive change and protect the investments of stockholders in HealthWarehouse.com.  In July 2016, RIVC nominated four candidates for election at the Company's 2016 Annual Meeting of Stockholders.  RIVC then joined similarly motivated stockholders in a group, and filed with the Securities and Exchange Commission (the "SEC") a definitive proxy statement and accompanying form of proxy card in connection with the Company's 2016 Annual Meeting of Stockholders.  Further information about RIVC can be found in the Definitive Proxy materials on file with the SEC, and at RIVC's website at www.Rxinvestors.com.

Cautionary Statement Regarding Opinions and Forward-Looking Statements

Certain information contained herein constitutes "forward-looking statements" with respect to HealthWarehouse.com, Inc. which can be identified by the use of forward-looking terminology such as "may," "will," "seek," "should," "could," "expect," "anticipate," "project," "estimate," "intend," "continue" or "believe" or the negatives thereof or other variations thereon or comparable terminology. Such statements are not guarantees of future performance or activities. Due to various risks, uncertainties and assumptions, actual events or results or actual performance may differ materially from those reflected or contemplated in such forward-looking statements. The opinions of Rx Investor Value Corporation ("RIVC") are for general informational purposes only and do not have regard to the specific investment objective, financial situation, suitability or particular need of any specific person, and should not be taken as advice on the merits of any investment decision. This material does not recommend the purchase or sale of any security. RIVC reserves the right to change any of its opinions expressed herein at any time as it deems appropriate. RIVC disclaims any obligation to update the information contained herein. RIVC may purchase additional HEWA shares or sell all or a portion of its shares or trade in securities relating to such shares.